A replication-competent oncolytic adenovirus lacking E1B suppresses the production of the pro-angiogenic factor VEGF-A in pancreatic cancer cells by disrupting the interaction between the transcription factor HIF-1α and the transcriptional co-activator p300 [60]. This evidence concerns the gene EP300 and pancreatic neoplasm.